Both in Pharmaceuticals
Gossamer Bio vs Citius Oncology
Over the past year GOSS returned −95.1% and CTOR returned −67.1%; their daily moves had a correlation of 0.01.
GOSS −95.1% CTOR −67.1%Growth of $1, one year, split-adjusted
| Metric | GOSS | CTOR |
|---|---|---|
| Price | $9.28 | $0.5500 |
| Market cap | $56.8M | $58.2M |
| Today | −1.80% | −7.42% |
| 1 month | −12.9% | −37.0% |
| 6 months | −65.5% | −42.5% |
| Year to date | −96.3% | −45.0% |
| 1 year | −95.3% | −68.6% |
| Revenue growth (YoY) | −19.6% | — |
| Gross margin | 100.0% | 67.1% |
| Net margin | 182.9% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 8.2× |
| Net cash | $20.9M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 1,265.9% | 98.9% |
| Short % of float | 24.9% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).